Table 3 Ultraviolet–visible spectroscopic measurements of the synthesized BER-BSA and BSA NPs
From: Berberine-loaded albumin nanoparticles reverse aflatoxin B1-induced liver hyperplasia
Formulation | BER content (mg) | NPs content (mg) | EE (%) | LC (%) | SY (%) |
|---|---|---|---|---|---|
BSA NPs | …… | 191.7 ± 2.7 | …… | …. | 95.8 ± 2.1 |
BER-BSA NPs | 15.7 ± 0.1 | 203.7 ± 5.4 | 78.5 ± 1.7 | 7.71 ± 0.3 | 92.6 ± 1.8 |